Gastrointestinal and Cardiovascular Risks of Aceclofenac-Serratopeptidase Combination Therapy
Gastrointestinal Risks
- The American College of Gastroenterology notes that all NSAIDs, including aceclofenac, carry a 5-6 fold increased risk of serious gastrointestinal complications compared to non-users, with risk factors substantially amplifying this baseline hazard 1, 2
- The American College of Cardiology reports that serious GI bleeding or perforation occurs in 1 in 20 chronic NSAID users overall, and 1 in 7 older adults 3
- Annual mortality due to NSAID use is 15.3 deaths per 100,000 users, according to the American Gastroenterological Association 1, 2
- NSAIDs account for 30% of upper GI-related hospitalizations, as stated by the American College of Cardiology 3
- Age >65 years increases the risk of GI complications 2-3.5 fold compared to younger patients, according to the European Society for Clinical Gastroenterology 4, 5, 1, 2
- Prior peptic ulcer or GI bleeding increases the risk of recurrent events 2.5-4 fold, as reported by the European Society for Clinical Gastroenterology 4, 5, 1, 2
- Concomitant aspirin use increases the risk of GI complications over 10-fold compared to non-users, according to the American Gastroenterological Association 1, 2
- Concomitant corticosteroids increase the risk of GI complications 2-fold, as stated by the European Society for Clinical Gastroenterology 4, 5
- Concomitant anticoagulants (warfarin) increase the risk of GI complications 3-fold, according to the European Society for Clinical Gastroenterology 4, 5
- The American College of Gastroenterology recommends prescribing a proton pump inhibitor (PPI) concurrently with aceclofenac for patients with risk factors, as PPIs reduce bleeding ulcer risk by 75-85% in high-risk NSAID users 4, 5, 3, 7
- Standard PPI dosing is omeprazole 20 mg daily or equivalent, as recommended by the American Gastroenterological Association 7
Cardiovascular Risks
- The American Heart Association notes that NSAIDs as a class do not significantly increase or decrease cardiovascular events at standard doses, though individual agents may differ, according to the European Society of Cardiology 4, 5
- Blood pressure elevation is a mean increase of approximately 5 mm Hg with NSAID use, as reported by the American College of Cardiology 6
- Heart failure exacerbation is possible with all NSAIDs through sodium retention, according to the American Heart Association 1, 2
- Regular blood pressure monitoring is recommended during NSAID therapy, as stated by the American College of Cardiology 6
Renal Risks
- The National Kidney Foundation notes that all NSAIDs, including aceclofenac, can cause renal complications through prostaglandin inhibition, and recommends using the lowest effective dose for the shortest duration to minimize renal toxicity 8, 2